<DOC>
	<DOCNO>NCT00326131</DOCNO>
	<brief_summary>The first purpose study determine body absorbs , metabolizes , eliminate single dose BMS-275183 ( label radioactive carbon ) . Secondly , measure level BMS-275183 blood , study safety drug , see effect cancer .</brief_summary>
	<brief_title>A Phase I Study Single Dose Radio-labeled BMS-275183 Patients With Advanced Cancer</brief_title>
	<detailed_description />
	<criteria>Nonhematological malignancy progress standard therapy No 3 prior chemotherapy give advanced cancer Adequate renal , hepatic hematologic function Uncontrolled significant pulmonary cardiovascular disease Active Brain metastases Inability swallow capsule Serious uncontrolled medical disorder active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>